Phenotypic Switching and β-N-Acetylhexosaminidase Activity of the Pathogenic Yeast Trichosporon asahii

Microbiology and Immunology

Volumn 48, Issue 4, 2004, Pages 237-242

  Ichikawa, Tomoe ^a   Sugita, Takashi ^a   Wang, Li ^b,c   Yokoyama, Koji ^b   Nishimura, Kazuko ^b   Nishikawa, Akemi ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c JILIN UNIVERSITY   (China)

Author keywords

Phenotype; Trichosporon asahii; N Acetylhexosaminidase

Indexed keywords

AGAR; ASPARTIC PROTEINASE; BETA N ACETYLHEXOSAMINIDASE; ENZYME; PHOSPHOLIPASE; VIRULENCE FACTOR;

ARTICLE; CANDIDA ALBICANS; CATALYSIS; COLONY FORMATION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; ENZYME RELEASE; FUNGAL MORPHOLOGY; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; MYCOSIS; NONHUMAN; PATHOGENICITY; PHENOTYPIC VARIATION; TRICHOSPORON ASAHII; TRICHOSPORON BEIGELII; TRICHOSPORON INKIN; TRICHOSPORON MUCOIDES; YEAST;

CANDIDA; CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; FUNGI; TRICHOSPORON ASAHII; TRICHOSPORON BEIGELII; TRICHOSPORON INKIN; TRICHOSPORON MUCOIDES; TRICHOSPORON OVOIDES;

EID: 1942421797     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03519.x     Document Type: Article

References (31)

1. Aronson, N.N., Jr., and Kuranda, M.J. 1989. Lysosomal degradation of Asn-linked glycoproteins. FASEB J. 3: 2615-2622.
2. De Bernardis, F., Mondello, F., San Millan, R., Ponton, J., and Cassone, A. 1999. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J. Clin. Microbiol. 37: 3481-3486.
3. De Bernardis, F., Sullivan, P.A., and Cassone, A. 2001. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med. Mycol. 39: 303-313.
4. Fries, B.C., Goldman, D.L., Cherniak, R., Ju, R., and Casadevall, A. 1999. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect. Immun. 67: 6076-6083.
5. Ghannoum, M.A. 2000. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 13: 122-143.
6. Goldman, D.L., Fries, B.C., Franzot, S.P., Montella, L., and Casadevall, A. 1998. Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc. Natl. Acad. Sci. U.S.A. 95: 14967-14972.
7. Guého, E., Improvisi, L., de Hoog, G.S., and Dupont, B. 1994. Trichosporon on humans: a practical account. Mycoses 37: 3-10.
8. Hellstein, J., Vawter-Hugart, H., Fotos, P., Schmid, J., and Soll, D.R. 1993. Genetic similarity and phenotypic diversity of commensal and pathogenic strains of Candida albicans isolated from the oral cavity. J. Clin. Microbiol. 31: 3190-3199.
9. Herbrecht, R., Koening, H., Waller, K., Liu, L., and Guého, E. 1993. Trichosporon infections: clinical manifestations and treatment. J. Mycol. Med. 3: 129-136.
10. Hoy, J., Hsu, K.C., Rolston, K., Hopfer, R.L., Luna, M., and Bodey, G.P. 1986. Trichosporon beigelii infection: a review. Rev. Infect. Dis. 8: 959-967.
11. Hube, B., Monod, M., Schofield, D.A., Brown, A.J., and Gow, N.A. 1994. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol. 14: 87-99.
12. Jenkinson, H.F., and Shepherd, M.G. 1987. A mutant of Candida albicans deficient in β-N-acetylglucosaminidase (chitobiase). J. Gen. Microbiol. 133: 2097-2106.
13. Liu, H. 2001. Transcriptional control of dimorphism in Candida albicans. Curr. Opin. Microbiol. 4: 728-735.
14. Lyman, C.A., Garrett, K.F., Pizzo, P.A., and Walsh, T.J. 1994. Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging opportunistic pathogen. J. Infect. Dis. 170: 1557-1565.
15. Lyman, C.A., Devi, S.J., Nathanson, J., Frasch, C.E., Pizzo, P.A., and Walsh, T.J. 1995. Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity. J. Clin. Microbiol. 33: 126-130.
16. Nahass, G.T., Rosenberg, S.P., Leonardi, C.L., and Penneys, N.S. 1993. Disseminated infection with Trichosporon beigelii. Arch. Dermatol. 129: 1020-1023.
17. Niimi, K., Niimi, M., Shepherd, M.G., and Cannon, R.D. 2000. N-Acetylhexosaminidase of the pathogenic yeast Candida albicans. Res. Dev. Microbiol. 4: 85-100.
18. Niimi, K., Shepherd, M.G., and Cannon, R.D. 2001. Distinguishing Candida species by β-N-acetylhexosaminidase activity. J. Clin. Microbiol. 39: 2089-2097.
19. Odds, E.C. 1997. Switch of phenotype as an escape mechanism of the intruder. Mycoses 40: 9-12.
20. Perfect, J.R., and Casadevall, A. 2002. Cryptococcosis. Infect. Dis. Clin. North Am. 16: 837-874.
21. Perparim, K., Nagai, H., Hashimoto, A., Goto, Y., Tashiro, T., and Nasu, M. 1996. In vitro susceptibility of Trichosporon beigelii to antifungal agents. J. Chemother. 8: 445-448.
22. Price, M.F., Wilkinson, I.D., and Gentry, L.O. 1982. Plate method for detection of phospholipase activity of Candida albicans. Sabouraudia 20: 7-14.
23. Ram, S.P., Romana, L.K., Shepherd, M.G., and Sullivan, P.A. 1984. Exo-(1, 3)-β-glucanase, autolysin and trehalase activities during yeast growth and germ-tube formation in Candida albicans. J. Gen. Microbiol. 130: 1227-1236.
24. Rongrungruang, Y., and Levitz, S.M. 1999. Interactions of Penicillium marneffei with human leukocytes in vitro. Infect. Immun. 67: 4732-4736.
25. Soll, D.R. 1992. High-frequency switching in Candida albicans. Clin. Microbiol. Rev. 5: 183-203.
26. Soll, D.R., Morrow, B., and Srikantha, T. 1993. High-frequency phenotypic switching in Candida albicans. Trends Genet. 9: 61-65.
27. Sugita, T., Nishikawa, A., and Shinoda, T. 1998. Identification of Trichosporon asahii by PCR based on sequences of the internal transcribed spacer regions. J. Clin. Microbiol. 36: 2742-2744.
28. Sugita, T., Nishikawa, A., Ikeda, R., and Shinoda, T. 1999. Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification. J. Clin. Microbiol. 37: 1985-1993.
29. Tashiro, T., Nagai, H., Kamberi, P., Goto, Y., Kikuchi, H., Nasu, M., and Akizuki, S. 1994. Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review. Eur. J. Clin. Microbiol. Infect. Dis. 13: 218-224.
30. Toriumi, Y., Sugita, T., Nakajima, M., Matsushima, T., and Shinoda, T. 2002. Antifungal pharmacodynamic characteristics of amphotericin B against Trichosporon asahii, using time-kill methodology. Microbiol. Immunol. 46: 89-93.
31. Walsh, T.J. 1989. Trichosporonosis. Infect. Dis. Clin. North Am. 3: 43-52.